Products & Pipeline
We are developing and commercializing novel Digital Therapeutics for a variety of indications including smoking cessation, major depressive disorder, schizophrenia, insomnia, acute coronary syndrome, migraine, overactive bladder, chronic low back pain, and obesity.
CT-100: Click Neurobehavioral Intervention (CNI) Platform
Product
Indication
Collaborator
Phase 1
Discovery
Discovery
Phase 2
Dev/Pilot
Dev/Pilot
Phase 3
Pivotal
Pivotal
Regulatory
Launch
Phase
CT-101
Clickotine®
Clickotine®
Smoking Cessation
Launch
CT-152
Major Depressive Disorder (MDD)
Otsuka
Regulatory
CT-155
Schizophrenia
Boehringer Ingelheim
Pivotal
CT-132
Migraine
Pivotal
CT-156
Schizophrenia
Boehringer Ingelheim
Dev/Pilot
CT-102
Opioid Use Disorder (OUD)
Indivior
Discovery
CT-133
Multiple Sclerosis (MS)
Discovery
CT-171
Atopic Dermatitis
Discovery
CT-181
Obesity
Discovery
CT-191
Oncology
Discovery
CT-141
Clickadian™
Clickadian™
Insomnia
Discovery
CT-111
Clickheart™
Clickheart™
Acute Coronary Syndrome
Discovery
Clickotine®
CT-101
An all in one, comprehensive digital smoking cessation program
learn more
![](https://images.ctfassets.net/2cin6yp65173/PHmAaqvbOHFxQdXqMcxLv/910e88d7a4e125ff29ca606c016f7096/product-list-image-1_cropped.jpg?w=1440&h=2052&fl=progressive&q=60&fm=jpg&bg=transparent)
Major Depressive Disorder (MDD)
CT-152
Click is researching multiple cognitive exercises for the treatment of MDD.
![](https://images.ctfassets.net/2cin6yp65173/2MX4wXSJZcgKJxQvVff36A/f56af9339e5eeb6fad47a792d0853ed9/product-list-image-2.jpg?w=1440&h=2052&fl=progressive&q=60&fm=jpg&bg=transparent)
Schizophrenia
CT-155
Confidential
![](https://images.ctfassets.net/2cin6yp65173/2293JGD1rwbBDZnfYxBd2n/c4d94c6f2d987e505e42463acae3d5ea/product-list-image-5.jpg?w=1440&h=2052&fl=progressive&q=60&fm=jpg&bg=transparent)
Migraine
CT-132
Confidential
![](https://images.ctfassets.net/2cin6yp65173/5aLgG7oYzej2LOojtU46nM/ac4cc777b5c9f583df77659e00c82958/product-list-image-4.jpg?w=1440&h=2052&fl=progressive&q=60&fm=jpg&bg=transparent)
Schizophrenia
CT-156
Confidential
![](https://images.ctfassets.net/2cin6yp65173/sec06H2Z5CZaUsnGq4QyL/0e2e7dda44c94c81e6fba20ac87daf89/product-list-image-8.jpg?w=1200&h=800&fl=progressive&q=60&fm=jpg&bg=transparent)
Clickadian™
CT-141
Clickadian is under development as a clinically-validated fully digital program for insomnia
learn more
![](https://images.ctfassets.net/2cin6yp65173/6cdcuVOYDUgaErfZqCQCkM/e184768856e8f8c2e74d2a63c96dbff5/product-list-image-3.jpg?w=1440&h=2052&fl=progressive&q=60&fm=jpg&bg=transparent)
Clickheart™
CT-111
Clickheart is under development as a clinically-validated digital program for acute coronary syndrome
learn more
![](https://images.ctfassets.net/2cin6yp65173/1DdlBGxlpMKQQpS6uGUGHz/bbb1ae0a4e3ac9025522ff72067a661e/product-list-image-6_cropped.jpg?w=1440&h=2052&fl=progressive&q=60&fm=jpg&bg=transparent)
Additional Products in Research & Development
CT-131
Chronic Lower
Back Pain
Back Pain
CT-161
Overactive
Bladder
Bladder
CT-171
Atopic
Dermatitis
Dermatitis
CT-181
Obesity
CT-191
Oncology
-
Chronic Kidney
Disease
Disease
-
Chronic Obstructive
Pulmonary Disease
Pulmonary Disease
-
Osteoarthritis
Products in development are investigational Digital Therapeutics not for sale. FDA has not yet evaluated the safety or effectiveness of these products.